Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Aditya Birla Sun Life AMC Ltd. The fund was launched on 11 July 2019 and is managed by Dhaval Shah. As of 15 October 2026, the fund has an AUM of ₹1,077.52 Cr and its latest NAV is ₹34.23. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹1,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Torrent Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Apollo Hospitals Enterprise Ltd, Cipla Ltd, and J.B. Chemicals & Pharmaceuticals Ltd. The fund has delivered 10.6% returns over the last 1 year, 17.5% annualised returns over 3 years, 11.5% annualised returns over 5 years, and 18.4% annualised returns since inception.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






